全文获取类型
收费全文 | 796篇 |
免费 | 34篇 |
国内免费 | 28篇 |
专业分类
儿科学 | 32篇 |
妇产科学 | 10篇 |
基础医学 | 88篇 |
口腔科学 | 14篇 |
临床医学 | 72篇 |
内科学 | 109篇 |
皮肤病学 | 15篇 |
神经病学 | 41篇 |
特种医学 | 159篇 |
外科学 | 59篇 |
综合类 | 127篇 |
预防医学 | 41篇 |
眼科学 | 2篇 |
药学 | 56篇 |
1篇 | |
肿瘤学 | 32篇 |
出版年
2023年 | 6篇 |
2021年 | 5篇 |
2020年 | 3篇 |
2019年 | 2篇 |
2018年 | 8篇 |
2017年 | 8篇 |
2016年 | 6篇 |
2015年 | 7篇 |
2014年 | 13篇 |
2013年 | 27篇 |
2012年 | 24篇 |
2011年 | 21篇 |
2010年 | 30篇 |
2009年 | 37篇 |
2008年 | 30篇 |
2007年 | 43篇 |
2006年 | 29篇 |
2005年 | 19篇 |
2004年 | 23篇 |
2003年 | 22篇 |
2002年 | 15篇 |
2001年 | 14篇 |
2000年 | 15篇 |
1999年 | 16篇 |
1998年 | 43篇 |
1997年 | 38篇 |
1996年 | 40篇 |
1995年 | 24篇 |
1994年 | 22篇 |
1993年 | 22篇 |
1992年 | 10篇 |
1991年 | 7篇 |
1990年 | 11篇 |
1989年 | 24篇 |
1988年 | 21篇 |
1987年 | 18篇 |
1986年 | 25篇 |
1985年 | 23篇 |
1984年 | 7篇 |
1983年 | 10篇 |
1982年 | 17篇 |
1981年 | 10篇 |
1980年 | 13篇 |
1979年 | 4篇 |
1978年 | 8篇 |
1977年 | 9篇 |
1976年 | 10篇 |
1975年 | 8篇 |
1955年 | 2篇 |
1953年 | 2篇 |
排序方式: 共有858条查询结果,搜索用时 15 毫秒
211.
212.
Selection of platelets for refractory patients by HLA matching and prospective crossmatching 总被引:2,自引:0,他引:2
G Moroff ; G Garratty ; JM Heal ; BR MacPherson ; D Stroncek ; ST Huang ; W Ho ; LD Petz ; MF Leach ; SS Lennon ; et al. 《Transfusion》1992,32(7):633-640
A multi-site clinical study compared platelets chosen for refractory patients by prospective platelet crossmatching using stored donor platelets and HLA-based selection. Seventy-three patients who were refractory to random-donor platelets received two plateletpheresis components, one chosen by HLA-based criteria and the other by crossmatching. Patients were carefully evaluated to exclude nonimmune factors that could adversely affect transfusion results. Each of the five study sites used a crossmatch procedure with which it had experience. Results from this study indicate the following: 1) The overall rate of successful transfusion was similar when an HLA-based method of donor selection that includes all grades of matching and mismatching was compared to a crossmatch-based method of donor selection. 2) HLA-based selection that restricts recipients to grade A and BU matches was superior to a selection method based upon crossmatching alone. Donor selection based on HLA matching (grades A or BU) was also superior to selection based on any degree of HLA mismatching (grades BX, C, or D). 3) Selection of donors based on HLA-cross-reactive groups (defined by in vitro serologic crossreactivity) was no more successful than that based on grade C and D mismatches and was no more successful than selection by crossmatching alone. 4) Lymphocytotoxic and platelet antibodies were not detected in many of the enrolled patients, even though patients demonstrating nonimmune factors were eliminated from the study. It can be concluded that HLA-compatible (grades A and BU) platelets provide optimal support for refractory patients, but that crossmatch-selected platelets are acceptable as an alternative component. 相似文献
213.
Endoscopic management of postoperative bile leak 总被引:14,自引:0,他引:14
VA SARASWAT G. CHOUDHURI BC SHARMA DK AGARWAL R. GUPTA SS BAIJAL SS SIKORA R. SAXENA VK KAPOOR 《Journal of gastroenterology and hepatology》1996,11(2):148-151
Significant bile leak is an uncommon but serious complication of biliary tract surgery. Of twenty-five patients presenting with postoperative bile leak, 11 had complete tie-off of common bile duct and required surgery, while the remaining 14 had injury without complete obstruction and could be managed by endoscopic methods. Of these 14 cases, bile leak occurred from the cystic duct in 11 patients and from the common hepatic duct, right hepatic duct and left hepatic duct in one patient each. Endoscopic procedures performed included sphincterotomy alone (four patients), sphincterotomy and stent placement (seven patients) and sphincterotomy followed by nasobiliary catheter drainage (three patients). There was no technical failure and bile leak was stopped in all patients. One patient died of haemobilia 5 days after stent placement. When technically feasible, postoperative bile leak can be managed safely and effectively by endoscopic methods, obviating the need for surgical reexploration. 相似文献
214.
Ig VH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance 总被引:5,自引:1,他引:5
Plasma cell tumors display a wide spectrum of clinical progression, ranging from aggressive multiple myeloma to a benign form known as monoclonal gammopathy of undetermined significance (MGUS), which requires no treatment. Because both diseases involve mature Ig- secreting plasma cells, the reason for this variation in malignant behavior is unclear. However, assessment of malignant potential is desirable for choice of treatment protocols. Ig variable (VH) gene sequences analysis has previously shown the tumor cell of multiple myeloma to be postfollicular, with mutated homogeneous clonal sequences indicating no continuing exposure to the somatic hypermutation mechanism, and this was confirmed in 7 of 7 patients. Comparison of the VH gene sequences in the monoclonal cells in MGUS yielded a different result, with 3 of 7 patients demonstrating mutated heterogeneous sequences consistent with the tumor cells remaining under the influence of the mutator. In 1 of 3 of these patients, an IgM-positive precursor cell was identified that expressed heterogeneous VH sequences similar to those of the isotype-switched plasma cell. These results indicate that the clonal cells in MGUS differ from those in myeloma and suggest that the difference may reflect malignant potential. 相似文献
215.
216.
Jurgen AHR Claassen Aisha SS Meel-van den Abeelen David M Simpson Ronney B Panerai 《Journal of cerebral blood flow and metabolism》2016,36(4):665-680
Cerebral autoregulation is the intrinsic ability of the brain to maintain adequate cerebral perfusion in the presence of blood pressure changes. A large number of methods to assess the quality of cerebral autoregulation have been proposed over the last 30 years. However, no single method has been universally accepted as a gold standard. Therefore, the choice of which method to employ to quantify cerebral autoregulation remains a matter of personal choice. Nevertheless, given the concept that cerebral autoregulation represents the dynamic relationship between blood pressure (stimulus or input) and cerebral blood flow (response or output), transfer function analysis became the most popular approach adopted in studies based on spontaneous fluctuations of blood pressure. Despite its sound theoretical background, the literature shows considerable variation in implementation of transfer function analysis in practice, which has limited comparisons between studies and hindered progress towards clinical application. Therefore, the purpose of the present white paper is to improve standardisation of parameters and settings adopted for application of transfer function analysis in studies of dynamic cerebral autoregulation. The development of these recommendations was initiated by (but not confined to) the Cerebral Autoregulation Research Network (CARNet – www.car-net.org). 相似文献
217.
NJ Gogtay KD Kamtekar SS Dalvi SS Mehta AR Chogle U Aigal NA Kshirsagar 《BMC infectious diseases》2006,6(1):16-4
Background
The WHO recommends that adults with uncomplicated P. falciparum successfully treated with a blood schizonticide receive a single dose of primaquine (PQ) 45 mg as a gametocytocidal agent. An earlier pilot study suggested that 75 mg of bulaquine (BQ), of which PQ is a major metabolite, may be a useful alternate to PQ. 相似文献218.
AMSA was evaluated in the treatment of 109 adults with previously treated acute leukemia. Of the 102 evaluable patients, 82 had AML, 17 ALL, and 3 CML in blastic phase. A number of different dose schedules of AMSA were explored, and we conclude that the optimum dose of AMSA for remission induction in acute leukemia is 120 mg/sq m/day for 5 days. Complete remissions were observed in 23 (28%) patients with AML and in 1 patient with ALL. Patients who achieved complete remission were maintained on AMSA using a dose of 30-40 mg/sq m/day for 5 days repeated at 4-wk intervals. The median duration of complete remission was 12 wk (3-59 wk), and the responders survived significantly longer than the failures (27 wk versus 8 wk, p = 0.002). The side effects associated with AMSA therapy included mild nausea and vomiting, stomatitis, diarrhea, phlebitis, alopecia, and myelosuppression-related infections. Our results indicate that AMSA is a useful new antileukemic agent for the treatment of relapsed acute leukemia and appears to have activity comparable to that of the currently available drugs, such as cytarabine and the anthracycline antibiotics. 相似文献
219.
The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants 总被引:13,自引:1,他引:13
We describe here a test for lupus anticoagulants based on a modified Russell viper venom time (RVVT), using limiting amounts of phospholipid and venom. We have studied 29 patients with a prolonged dilute RVVT. Five of the 29 had a normal activated partial thromboplastin time and three of 14 tested by the tissue thromboplastin inhibition test were normal. In 17 of 19 patients tested, the dilute RVVT was completely normal when ionophore-treated platelets were substituted for phospholipid; the remaining two patients, both with very long phospholipid-dependent dilute RVVT's, were nearly completely normalized. The dilute RVVT is not prolonged in the presence of antibodies to factors VIII, IX, or XI. Thus, the dilute RVVT appears to be a simple, reproducible, sensitive, and relatively specific method for the detection of lupus anticoagulants. 相似文献
220.